Aldeyra Therapeutics

3 followers

‌

Aldeyra Therapeutics develops treatments for aldehyde toxicity-related diseases including Sjögren-Larsson Syndrome (SLS) and noninfectious anterior uveitis.

Industries

Pharmaceutical

Headquarters

Lexington, United States

Employees

11-50

Links

Org chart

Todd C. Brady

CEO & President

Todd C. Brady

Collapse

Christopher Pearson

Vice President, Commercial Development and Strategy

David J. Clark

Chief Medical Officer

David Noskowitz

Vice President, Regulatory Affairs

Lise L. Kjems

Vice President, Clinical Development

Stephen G. Machatha

Senior Vice President, Technical Operations

Annalisa Webb

Assistant Controller

Teams

Leadership Team

6 members

Clinical and Commercial Development

5 members

Quality and Regulatory

3 members

Finance

2 members

Similar companies

Rocket Pharmaceuticals

2 followers

Biotrial Inc.

1 follower

Bristol-Myers Squibb

199 followers

Walgreens Boots Alliance

108 followers

Viatris

37 followers

Alnylam Pharmaceuticals

21 followers

Catalent

18 followers

Organon

17 followers

Parexel

8 followers

VaxCare

1 follower

Nektar Therapeutics

7 followers

Explore companies